Literature DB >> 20432052

Changing etiology of community-acquired bacterial meningitis in adults: a nationwide multicenter study in Korea.

S-Y Moon1, D R Chung, S-W Kim, H H Chang, H Lee, D S Jung, Y-S Kim, S I Jung, S Y Ryu, S T Heo, C Moon, H K Ki, J S Son, K T Kwon, S Y Shin, J S Lee, S S Lee, J-Y Rhee, J-A Lee, M K Joung, H S Cheong, K R Peck, J-H Song.   

Abstract

Epidemiologic data on the etiologic organisms is important for appropriate empirical antibiotic treatment of bacterial meningitis. We identified the etiologies of community-acquired bacterial meningitis in Korean adults and the associated epidemiological factors. A retrospective, multicenter nationwide study was carried out. Patients 18 years of age or older with community-acquired bacterial meningitis with a confirmed pathogen were enrolled. Demographic, clinical, and microbiological data were collected. One hundred and ninety-five cases were collected. Streptococcus pneumoniae was the most common pathogen (50.8%), followed by Staphylococcus aureus (10.3%), Klebsiella pneumoniae (7.7%), Listeria monocytogenes (6.7%), and group B Streptococcus (3.1%). The penicillin resistance rate of the S. pneumoniae was 60.3%; 40.0% of the organisms were not susceptible to third-generation cephalosporins. The combination of third-generation cephalosporin with vancomycin was used in 76.3% of cases. Steroids were given before or with the first dose of antibiotics in 37.4% of patients. The 30-day mortality rate was 20.5% and neurological sequelae developed in 15.6% of cases. S. pneumoniae was the most common organism identified in community-acquired bacterial meningitis among Korean adults. S. aureus, K. pneumoniae, L. monocytogenes, and group B Streptococcus were also common. S. pneumoniae had high rates of resistance to penicillin and third-generation cephalosporins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20432052     DOI: 10.1007/s10096-010-0929-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  29 in total

Review 1.  Epidemiology of human listeriosis.

Authors:  A Schuchat; B Swaminathan; C V Broome
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  Acute bacterial meningitis in adults. A 20-year overview.

Authors:  B Sigurdardóttir; O M Björnsson; K E Jónsdóttir; H Erlendsdóttir; S Gudmundsson
Journal:  Arch Intern Med       Date:  1997-02-24

3.  Adult bacterial meningitis in Southern Taiwan: epidemiologic trend and prognostic factors.

Authors:  C H Lu; W N Chang; H W Chang
Journal:  J Neurol Sci       Date:  2000-12-15       Impact factor: 3.181

Review 4.  Acute bacterial meningitis in adults. A 12-year review.

Authors:  A S Hussein; S D Shafran
Journal:  Medicine (Baltimore)       Date:  2000-11       Impact factor: 1.889

Review 5.  Meningococcal polysaccharide-protein conjugate vaccines.

Authors:  Matthew D Snape; Andrew J Pollard
Journal:  Lancet Infect Dis       Date:  2005-01       Impact factor: 25.071

6.  Risk factor analysis of invasive liver abscess caused by the K1 serotype Klebsiella pneumoniae.

Authors:  J-K Kim; D R Chung; S H Wie; J H Yoo; S W Park
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-29       Impact factor: 3.267

7.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

Review 8.  Steroids in adults with acute bacterial meningitis: a systematic review.

Authors:  Diederik van de Beek; Jan de Gans; Peter McIntyre; Kameshwar Prasad
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

9.  Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study.

Authors:  H W Pfister; W Feiden; K M Einhäupl
Journal:  Arch Neurol       Date:  1993-06

10.  Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.

Authors:  Wen-Chien Ko; David L Paterson; Anthanasia J Sagnimeni; Dennis S Hansen; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Joseph G McCormack; Victor L Yu
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  13 in total

Review 1.  The road less traveled - defining molecular commensalism with Streptococcus sanguinis.

Authors:  J Kreth; R A Giacaman; R Raghavan; J Merritt
Journal:  Mol Oral Microbiol       Date:  2016-09-20       Impact factor: 3.563

Review 2.  A rare case of meningoencephalitis by Listeria monocytogenes in systemic lupus erythematosus: case report and review.

Authors:  Tian-Yan Shi; Yong-Feng Zhang; Xu-Hua Shi; Xiao-Hong Wen; Xin Dong; Juan Meng; Hai-Yun Li; Xiao-Xu Yuan; Yi Zheng; Yue-Wu Lu
Journal:  Clin Rheumatol       Date:  2017-08-07       Impact factor: 2.980

3.  Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone?

Authors:  Soo-Youn Moon; Doo Ryeon Chung; Shin-Woo Kim; Hyun Ha Chang; Hyuck Lee; Dong Sik Jung; Yeon-Sook Kim; Sook In Jung; Seong Yeol Ryu; Sang Taek Heo; Chisook Moon; Hyun Kyun Ki; Jun Seong Son; Ki Tae Kwon; Sang Yop Shin; Jin Seo Lee; Seung Soon Lee; Ji-Young Rhee; Cheol-In Kang; Kyong Ran Peck; Jae-Hoon Song
Journal:  J Neurol       Date:  2012-01-06       Impact factor: 4.849

4.  Predictive risk factors for Listeria monocytogenes meningitis compared to pneumococcal meningitis: a multicenter case-control study.

Authors:  Seungjin Lim; Doo Ryeon Chung; Yeon-Sook Kim; Kyung Mok Sohn; Seung-Ji Kang; Sook-In Jung; Shin-Woo Kim; Hyun Ha Chang; Seung Soon Lee; In-Gyu Bae; Chisook Moon; Ji-Young Rhee; Jin Seo Lee; Hyun Kyun Ki; Hyun Ah Kim; Seong Yeol Ryu; Joon-Sup Yeom; Jun Seong Son; Soo-Youn Moon; Ki Tae Kwon; Hyuck Lee; Sang Taek Heo; Cheol-In Kang; Kyong Ran Peck; Jae-Hoon Song
Journal:  Infection       Date:  2016-08-19       Impact factor: 3.553

5.  Listeria monocytogenes meningitis in the Netherlands, 1985-2014: A nationwide surveillance study.

Authors:  Merel M Koopmans; Merijn W Bijlsma; Matthijs C Brouwer; Diederik van de Beek; Arie van der Ende
Journal:  J Infect       Date:  2017-04-15       Impact factor: 6.072

Review 6.  Epidemiology of Listeria monocytogenes prevalence in foods, animals and human origin from Iran: a systematic review and meta-analysis.

Authors:  Reza Ranjbar; Mehrdad Halaji
Journal:  BMC Public Health       Date:  2018-08-23       Impact factor: 3.295

7.  Characterization of a Listeria monocytogenes meningitis mouse model.

Authors:  Merel M Koopmans; JooYeon Engelen-Lee; Matthijs C Brouwer; Valery Jaspers; Wing Kit Man; Mercedes Vall Seron; Diederik van de Beek
Journal:  J Neuroinflammation       Date:  2018-09-07       Impact factor: 8.322

8.  Devastating Community-Acquired Bacterial Meningitis Caused by Hypervirulent Klebsiella pneumoniae in an Immunocompetent Patient.

Authors:  Hyunjoo Oh; Sang Taek Heo; Misun Kim; Chul Hoo Kang; Jeong Rae Yoo
Journal:  J Clin Neurol       Date:  2021-07       Impact factor: 3.077

9.  The spectrum of central nervous system infections in an adult referral hospital in Hanoi, Vietnam.

Authors:  Walter R Taylor; Kinh Nguyen; Duc Nguyen; Huyen Nguyen; Peter Horby; Ha L Nguyen; Trinh Lien; Giang Tran; Ninh Tran; Ha M Nguyen; Thai Nguyen; Ha H Nguyen; Thanh Nguyen; Giap Tran; Jeremy Farrar; Menno de Jong; Constance Schultsz; Huong Tran; Diep Nguyen; Bich Vu; Hoa Le; Trinh Dao; Trung Nguyen; Heiman Wertheim
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

10.  Characterization of Corosolic Acid as a KPC-2 Inhibitor That Increases the Susceptibility of KPC-2-Positive Bacteria to Carbapenems.

Authors:  Yonglin Zhou; Xiaohong Lv; Meishan Chen; Yan Guo; Rui Ding; Bin Liu; Xuming Deng; Jianfeng Wang
Journal:  Front Pharmacol       Date:  2020-07-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.